Long-Term Follow-up Study of Patients Who Received PB127 Ultrasound Imaging Agent

POINT Biopharma

Status: Terminated

Conditions: Coronary Artery Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT00584714

127-014-A

Details and patient eligibility

About

The purpose of this study is to collect longer term follow-up information concerning health and survival on selected patients who received PB127 for injectable suspension in the pivotal trial (127-014).

Enrollment: 300 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Patients enrolled in Protocol 127-014 who

1. Were enrolled in Stratum 1
2. Did not undergo angiography during study evaluation
3. Did not have a clinical oucome during the initial 6 month follow-up period as described in Protocol 127-014.